Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733372 | SCV000861436 | uncertain significance | not provided | 2018-05-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000733372 | SCV003500185 | likely benign | not provided | 2022-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002535326 | SCV003719094 | uncertain significance | Inborn genetic diseases | 2022-09-14 | criteria provided, single submitter | clinical testing | The c.3641C>T (p.T1214I) alteration is located in exon 30 (coding exon 30) of the WDR62 gene. This alteration results from a C to T substitution at nucleotide position 3641, causing the threonine (T) at amino acid position 1214 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |